SILVERARC CAPITAL MANAGEMENT, LLC
Position in TRVI — Trevi Therapeutics, Inc.
CIK 1816307
BOSTON, MA
Position in TRVI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,646,471
+$6,548,726 QoQ
Shares Held
678,095
+32.7% QoQ
Ownership
0.476%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
#50
of 216 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SILVERARC CAPITAL MANAGEMENT, LLC holds $802,586,993 across 53 Biotechnology names. TRVI ranks #21 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
206,234 | $55,006,732 | |
| 2 | CELC |
Celcuity Inc.
|
500,996 | $52,414,201 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
1,280,707 | $49,563,360 | |
| 4 | URGN |
UroGen Pharma Ltd.
|
1,301,979 | $47,912,827 | |
| 5 | IMNM |
Immunome Inc.
|
2,017,009 | $42,740,420 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
390,000 | $38,017,200 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
311,461 | $34,581,514 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
352,802 | $33,576,166 |
All Filings in TRVI
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,646,471 | 678,095 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,097,745 | 511,127 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,776,324 | 541,240 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,387,419 | 588,789 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,951,540 | 539,587 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,333,700 | 530,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,025,044 | 734,234 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,611,800 | 482,575 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,515,820 | 844,235 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,912,610 | 844,235 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,157,603 | 863,883 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,021,764 | 927,415 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,117,358 | 885,924 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,638,959 | 885,924 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,481,527 | 767,631 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,446,468 | 939,265 | Shares | Sole | 2022-10-28 | |
| No filing history on record for this holder in this stock. | ||||||